Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis
SETTING: Cross-contamination is not uncommon in mycobacteriology laboratories of high-income countries, as documented by bacterial genotyping. The extent of this problem in low-income countries is largely unknown, where this method is impractical.OBJECTIVE: To estimate the rate of cross-contaminatio...
Saved in:
Published in | The international journal of tuberculosis and lung disease Vol. 14; no. 8; pp. 1016 - 1023 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Paris, France
IUATLD
01.08.2010
International Union against Tuberculosis and Lung Disease |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | SETTING: Cross-contamination is not uncommon in mycobacteriology laboratories of high-income countries, as documented by bacterial genotyping. The extent of this problem in low-income countries is largely unknown, where this method is impractical.OBJECTIVE: To estimate the rate
of cross-contamination in a high-volume tuberculosis (TB) laboratory in South Africa.DESIGN: Simulated sputum specimens labelled with false names were sent from a TB clinic, interspersed with patient samples, and processed for culture and microscopy. Results were interpreted in the context
of the observed proportion of samples with positive microscopy and culture results.RESULTS: With microscopy, 6/190 (3.2%) simulated specimens were positive (estimated specificity = 96.8%). Considering the 881 positive microscopy results in 6093 clinical samples, we extrapolate that
19.3% (95%CI 7.0-42.8) of positive smears were false-positives. On culture, 2/190 (1.1%) of the simulated specimens were positive for Mycobacterium tuberculosis (estimated specificity = 98.9%). Considering the 1862 positive cultures from 6093 clinical samples, we estimate
that 2.4% (95%CI 0.3-8.8) of positive cultures were false-positives.CONCLUSION: Simulated specimens offer a simple means of estimating the proportion of false-positive results, providing information on all sources of potential error from the clinic, through the laboratory and to
reporting of results. |
---|---|
Bibliography: | 1027-3719(20100801)14:8L.1016;1- (R) Medicine - General ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1027-3719 1815-7920 |